Answers are grounded in this paper and cite their sources.
Gene-editing techniques have progressed rapidly in the past 5 years. There are already ongoing human somatic gene-editing clinical trials for multiple diseases. And there has been one purported scenario of human germline gene editing in late 2018. In this paper, we will review the current state of the technology, discuss the ethical and social issues that surround the various forms of gene editing, as well as review emerging stakeholder data from professionals, the 'general public' and individuals and families dealing with genetic diseases potentially treatable by gene editing.
No takes yet. Share an insight, caveat, or question.
Ormond et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: